Popular drugs like Ozemic and Monjauro aid in managing diabetes by lowering blood sugar levels. They have surged in popularity because they hasten weight loss. And this new class of drugs —GLP-1 ...
For decades, Melexis has run with very little or no debt. As of 2024, it has EUR 170 million in net debt, or 0.8 times its 2024 EBIT. We expect Melexis will distribute most of its free cash flow in ...